{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-21-003577","form_type":"8-K","ticker":"OSUR","cik":"0001116463","company_name":"ORASURE TECHNOLOGIES INC","filed_at":"2021-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.551700+00:00","generated_at":"2026-06-28T10:28:10.186670+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"OraSure Technologies retirement of GC Jack Jerrett; appoints Agnieszka Gallagher as successor","bullets":["Jack E. Jerrett to retire as SVP, General Counsel, Chief Compliance Officer and Secretary effective Dec 31, 2021.","Agnieszka M. Gallagher appointed as new General Counsel, Chief Compliance Officer and Secretary starting Nov 29, 2021.","Jerrett receives 12-month salary severance, accelerated vesting of equity, and 2021 bonus at 40% of base salary.","Gallagher joins from Alnylam Pharmaceuticals; previously held senior legal/compliance roles at ViiV, GSK, Novartis, Medtronic, Pfizer."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-21-003577","json":"https://secwatch.observer/filing/0000950170-21-003577.json","markdown":"https://secwatch.observer/filing/0000950170-21-003577.md","text":"https://secwatch.observer/filing/0000950170-21-003577.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1116463/000095017021003577/0000950170-21-003577-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1116463/000095017021003577/osur-20211108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T10:28:10.186670+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3e7876e02e","claim":"Agnieszka M. Gallagher was appointed as General Counsel, Chief Compliance Officer and Secretary at ORASURE TECHNOLOGIES INC.","evidence_excerpt":"Ms. Agnieszka M. Gallagher who will join the Company on November 29, 2021 after most recently serving as Chief Ethics and Compliance Officer at Alhylam Pharmaceuticals.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1116463/000095017021003577/0000950170-21-003577-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"General Counsel, Chief Compliance Officer and Secretary"}],"fact_type":"executive_change"},{"claim_id":"cb7e83d9a5","claim":"Jack E. Jerrett departed as Senior Vice President, General Counsel, Chief Compliance Officer and Secretary at ORASURE TECHNOLOGIES INC.","evidence_excerpt":"Mr. Jack E. Jerrett, who currently serves as Senior Vice President, General Counsel, Chief Compliance Officer and Secretary for OraSure Technologies, Inc. (the “Company”), will be retiring from the Company effective December 31, 2021 (the “Retirement Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1116463/000095017021003577/0000950170-21-003577-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retiring"},{"label":"Role","value":"Senior Vice President, General Counsel, Chief Compliance Officer and Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}